Post by
SundayMovies on Mar 03, 2023 1:23pm
Proof that ONCY decline ROCHE
This lady added all she can... Now market missed this:
Andrew de Guttadauro:
"With several patients still receiving treatment, there is an opportunity for a truly impressive endpoint that we could sell ourselves short if we rush into a deal prematurely based on data that could improve over time.
With industry leaders such as Pfizer, Roche, Merck Serono, Bristol-Myers Squibb and Insight already familiar with pela thanks to collaborative clinical trials, we intend to run a methodical and competitive process that ensures we reach the best possible outcome for our shareholders."
Remember they are talking about survival that could improve over time.
Comment by
Lesalpes29 on Mar 04, 2023 9:38am
That could improved overtime... make a deal now... what will happen if it's declining! Hope we are not missing something interesting because the BOARD is too greedy. GL